Acupressure for Seasonal Allergic Rhinitis - a randomized controlled exploratory trial
- Conditions
- J30.1Allergic rhinitis due to pollen
- Registration Number
- DRKS00014310
- Lead Sponsor
- Charité Campus Charité Mitte
- Brief Summary
Results of this exploratory study indicate that self-applied acupressure is feasible, may improve disease-specific quality of life and reduce disease-related symptoms as well as anti-allergic medication intake in SAR patients. High-quality confirmatory studies including a sham-control group are needed in the future.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 42
1. Age 18-60
2. clinical diagnosis SAR and positive skin PRICK Test or RAST Test (minimum class 2) on grasses and birch pollen for more than 2 years
2.1. mean SAR symptoms in the last season: Visual Analogue Scale (VAS) =30 mm, =70mm
2.2. mean SAR symptoms in the last 7 days: Visual Analogue Scale (VAS) =30 mm, =70mm
2.3. existence of a positive Skin-Prick-Test or RAST (minimum Class 2)
3. Given linguistic and intellectual ability to fill diaries and questionnaires
4. medical indication for intake of oral Antihistamines and / or Corticosteroids as anti-allergic treatment
5. oral and written declaration of consent
1. Perennial Allergic Rhinitis or other forms of chronic Rhinitis
2. Allergic Asthma and / or mild to severe forms of Atopic Dermatitis
3. Other pulmonary disease, especially Tuberclosis
4. Autoimmune-Disease
5. Sever acute and / or chronic organic or psychatric disease
6. Medical history with anaphylactic shock
7. Intolerance of Antihistamines and / or Corticosteroids
8. specific immunotherapy / desensitizing therapy planned or carried out during study period
9. Pregnancy or nursing
10. Acupuncture treatment, acupressure and / or other complementary medicine treatments for SAR planned or carried out during study period
11. Participation in an other clinical study on SAR
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - Disease related quality of life (Rhinitis Quality of Life Questionnaire – RQLQ). Data to be collected in questionnaire and diary at baseline and after week 2, 4 and 8.<br>- Intake of disease related medication (Quantity and Frequency of Rescue Medication (Cetirizin, Corticosteroid): data to be collected daily in the diary during week 1 to 4 and in week 8. <br><br>- Quantity and Frequency of Rescue Medication (Cetirizin, Corticosteroid). The Rescue Medication Score of the last month is being calculated accordingly: 0-3: 0=no Cetirizin, 1 = Cetirizin 1x10mg/day, 2= Cetirizin 2x10mg/day, 3= oral Corticosteroid.<br>
- Secondary Outcome Measures
Name Time Method